Announcement PDF Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 1 / 4 Announcement Summary Entity name RECCE PHARMACEUTICALS LTD Announcement Type New announcement Date of this announcement Tuesday February 24, 2026 Details of +securities that have ceased ASX +security code Security description Number of +securities that have ceased The +securities have ceased due to Date of cessation RCEAN OPTION EXPIRING 22-FEB-2026 EX $1.56 8,415,000 Expiry of option or other convertible security without exercise or conversion 22/02/2026 Refer to next page for full details of the announcement Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 2 / 4 Part 1 - Announcement Details 1.1 Name of +Entity RECCE PHARMACEUTICALS LTD We (the entity named above) provide the following information about our issued capital. 1.2 Registered Number Type ACN Registration Number 124849065 1.3 ASX issuer code RCE 1.4 The announcement is 1.5 Date of this announcement 24/2/2026 New announcement Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 3 / 4 Part 2 - Details of +equity securities or +debt securities that have ceased ASX +Security Code and Description RCEAN : OPTION EXPIRING 22-FEB-2026 EX $1.56 Unquoted +equity securities that have ceased Number of securities that have ceased 8,415,000 Reason for cessation Expiry of option or other convertible security without exercise or conversion Date of cessation 22/2/2026 Is the entity paying any consideration for the cessation? Any other information the entity wishes to notify to ASX about the cessation? A total of 8,050,000 options were held by key management personnel. No Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 4 / 4 Part 3 - Issued capital following changes Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise: The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX) ASX +security code and description Total number of +securities on issue RCE : ORDINARY FULLY PAID 289,183,422 3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue RCEAW : OPTION EXPIRING 11-FEB-2027 EX $1.56 435,000 RCEAO : OPTION EXPIRING 07-NOV-2029 EX $0.56 2,690,000 RCEAU : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 1,125,000 RCEAP : OPTION EXPIRING 14-NOV-2029 EX $0.80 11,500,000 RCEAQ : WARRANTS 4,634,304 RCEAN : OPTION EXPIRING 22-FEB-2026 EX $1.56 0 Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.